{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:37:27Z","timestamp":1787647047037,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11060-024-04574-w","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T20:02:24Z","timestamp":1706558544000},"page":"569-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma"],"prefix":"10.1007","volume":"166","author":[{"given":"Pushan","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin F.","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"issue":"12","key":"4574_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cancergen.2012.10.009","volume":"205","author":"ML Goodenberger","year":"2012","unstructured":"Goodenberger ML, Jenkins RB (2012) Genetics of adult glioma. Cancer Genet 205(12):613\u2013621. https:\/\/doi.org\/10.1016\/j.cancergen.2012.10.009","journal-title":"Cancer Genet"},{"issue":"2","key":"4574_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97\u2013109. https:\/\/doi.org\/10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol"},{"issue":"Suppl 5","key":"4574_CR3","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol 21(Suppl 5):v1\u2013v100. https:\/\/doi.org\/10.1093\/neuonc\/noz150","journal-title":"Neuro Oncol"},{"issue":"3","key":"4574_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1055\/s-0034-1370791","volume":"40","author":"JT Jo","year":"2014","unstructured":"Jo JT, Schiff D, Perry JR (2014) Thrombosis in brain tumors. Semin Thromb Hemost 40(3):325\u2013331. https:\/\/doi.org\/10.1055\/s-0034-1370791","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"4574_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11060-015-1805-2","volume":"124","author":"S Yust-Katz","year":"2015","unstructured":"Yust-Katz S, Mandel JJ, Wu J et al (2015) Venous thromboembolism (VTE) and glioblastoma. J Neurooncol 124(1):87\u201394. https:\/\/doi.org\/10.1007\/s11060-015-1805-2","journal-title":"J Neurooncol"},{"issue":"4","key":"4574_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1227\/00006123-198204000-00004","volume":"10","author":"S Wakai","year":"1982","unstructured":"Wakai S, Yamakawa K, Manaka S, Takakura K (1982) Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery 10(4):437\u2013444. https:\/\/doi.org\/10.1227\/00006123-198204000-00004","journal-title":"Neurosurgery"},{"issue":"4","key":"4574_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1182\/blood-2015-02-626788","volume":"126","author":"J Donato","year":"2015","unstructured":"Donato J, Campigotto F, Uhlmann EJ et al (2015) Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study. Blood 126(4):494\u2013499. https:\/\/doi.org\/10.1182\/blood-2015-02-626788","journal-title":"Blood"},{"issue":"3","key":"4574_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1200\/JCO.2001.19.3.843","volume":"19","author":"MS Gordon","year":"2001","unstructured":"Gordon MS, Margolin K, Talpaz M et al (2001) Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol 19(3):843\u2013850. https:\/\/doi.org\/10.1200\/JCO.2001.19.3.843","journal-title":"J Clin Oncol"},{"issue":"1","key":"4574_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/jth.14336","volume":"17","author":"BJ Carney","year":"2019","unstructured":"Carney BJ, Uhlmann EJ, Puligandla M et al (2019) Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors. J Thromb Haemost 17(1):72\u201376. https:\/\/doi.org\/10.1111\/jth.14336","journal-title":"J Thromb Haemost"},{"issue":"12","key":"4574_CR10","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1093\/neuonc\/noac125","volume":"24","author":"L Reed-Guy","year":"2022","unstructured":"Reed-Guy L, Desai AS, Phillips RE et al (2022) Risk of intracranial hemorrhage with direct oral anticoagulants versus low molecular weight heparin in glioblastoma: A retrospective cohort study. Neuro Oncol 24(12):2172\u20132179. https:\/\/doi.org\/10.1093\/neuonc\/noac125","journal-title":"Neuro Oncol"},{"issue":"10","key":"4574_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"4574_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-030-79308-1_7","volume":"1342","author":"NK Majd","year":"2021","unstructured":"Majd NK, Dasgupta PR, de Groot JF (2021) Immunotherapy for Neuro-oncology. Adv Exp Med Biol 1342:233\u2013258. https:\/\/doi.org\/10.1007\/978-3-030-79308-1_7","journal-title":"Adv Exp Med Biol"},{"issue":"23","key":"4574_CR13","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1001\/jama.2021.21222","volume":"326","author":"WA Ray","year":"2021","unstructured":"Ray WA, Chung CP, Stein CM et al (2021) Association of rivaroxaban vs apixaban with major ischemic or hemorrhagic events in patients with atrial fibrillation. JAMA 326(23):2395\u20132404. https:\/\/doi.org\/10.1001\/jama.2021.21222","journal-title":"JAMA"},{"issue":"2","key":"4574_CR14","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1055\/s-0038-1649507","volume":"2","author":"PY Kim","year":"2018","unstructured":"Kim PY, Yeh CH, Dale BJ, Leslie BA, Stafford AR, Fredenburgh JC, Hirsh J, Weitz JI (2018) Mechanistic basis for the differential effects of rivaroxaban and apixaban on global tests of coagulation. TH Open 2(2):e190\u2013e201. https:\/\/doi.org\/10.1055\/s-0038-1649507","journal-title":"TH Open"},{"issue":"9","key":"4574_CR15","doi-asserted-by":"publisher","first-page":"e2583","DOI":"10.1097\/MD.0000000000002583","volume":"95","author":"JR Chen","year":"2016","unstructured":"Chen JR, Yao Y, Xu HZ, Qin ZY (2016) Isocitrate dehydrogenase (IDH)1\/2 mutations as prognostic markers in patients with glioblastomas. Medicine (Baltimore) 95(9):e2583. https:\/\/doi.org\/10.1097\/MD.0000000000002583","journal-title":"Medicine (Baltimore)"},{"key":"4574_CR16","doi-asserted-by":"publisher","unstructured":"Dasgupta P, Balasubramanyian V, de Groot JF, Majd NK (2023) Preclinical Models of Low-Grade Gliomas. Cancers (Basel) 15(3). https:\/\/doi.org\/10.3390\/cancers15030596","DOI":"10.3390\/cancers15030596"},{"issue":"6","key":"4574_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00401-016-1620-7","volume":"132","author":"D Unruh","year":"2016","unstructured":"Unruh D, Schwarze SR, Khoury L, Thomas C, Wu M, Chen L, Chen R, Liu Y, Schwartz MA, Amidei C, Kumthekar P, Benjamin CG, Song K, Dawson C, Rispoli JM, Fatterpekar G, Golfinos JG, Kondziolka D, Karajannis M, Pacione D, Zagzag D, McIntyre T, Snuderl M, Horbinski C (2016) Mutant IDH1 and thrombosis in gliomas. Acta Neuropathol 132(6):917\u2013930. https:\/\/doi.org\/10.1007\/s00401-016-1620-7","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04574-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04574-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04574-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T09:11:46Z","timestamp":1708333906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04574-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["4574"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04574-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"29 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved and met criteria for exemption from IRB review by University of Texas at Austin\u2019s Institutional Review Board (STUDY00003529).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}